BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 17877826)

  • 21. Identification of the nonstructural protein 4B of hepatitis C virus as a factor that inhibits the antiviral activity of interferon-alpha.
    Xu J; Liu S; Xu Y; Tien P; Gao G
    Virus Res; 2009 Apr; 141(1):55-62. PubMed ID: 19185598
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mechanism of HCV's resistance to IFN-α in cell culture involves expression of functional IFN-α receptor 1.
    Datta S; Hazari S; Chandra PK; Samara M; Poat B; Gunduz F; Wimley WC; Hauser H; Koster M; Lamaze C; Balart LA; Garry RF; Dash S
    Virol J; 2011 Jul; 8():351. PubMed ID: 21756311
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Interference with ERK and STAT signaling pathways and inhibition of hepatitis C virus replication by ribavirin.
    Zhao LJ; Wang W; Liu Y; Ren H; Qi ZT
    Antiviral Res; 2012 Nov; 96(2):260-8. PubMed ID: 22985631
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Altered expression and activation of signal transducers and activators of transcription (STATs) in hepatitis C virus infection: in vivo and in vitro studies.
    Larrea E; Aldabe R; Molano E; Fernandez-Rodriguez CM; Ametzazurra A; Civeira MP; Prieto J
    Gut; 2006 Aug; 55(8):1188-96. PubMed ID: 16120756
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Interferon-alpha and ribavirin resistance of Huh7 cells transfected with HCV subgenomic replicon.
    Aus dem Siepen M; Oniangue-Ndza C; Wiese M; Ross S; Roggendorf M; Viazov S
    Virus Res; 2007 Apr; 125(1):109-13. PubMed ID: 17254660
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Expression of hepatitis C virus proteins inhibits signal transduction through the Jak-STAT pathway.
    Heim MH; Moradpour D; Blum HE
    J Virol; 1999 Oct; 73(10):8469-75. PubMed ID: 10482599
    [TBL] [Abstract][Full Text] [Related]  

  • 27. HCV structural proteins interfere with interferon-alpha Jak/STAT signalling pathway.
    Luquin E; Larrea E; Civeira MP; Prieto J; Aldabe R
    Antiviral Res; 2007 Nov; 76(2):194-7. PubMed ID: 17675168
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antiviral potency analysis and functional comparison of consensus interferon, interferon-alpha2a and pegylated interferon-alpha2b against hepatitis C virus infection.
    Erickson AK; Seiwert S; Gale M
    Antivir Ther; 2008; 13(7):851-62. PubMed ID: 19043919
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cytopathic and noncytopathic interferon responses in cells expressing hepatitis C virus subgenomic replicons.
    Guo JT; Zhu Q; Seeger C
    J Virol; 2003 Oct; 77(20):10769-79. PubMed ID: 14512527
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Natural killer cells inhibit hepatitis C virus expression.
    Li Y; Zhang T; Ho C; Orange JS; Douglas SD; Ho WZ
    J Leukoc Biol; 2004 Dec; 76(6):1171-9. PubMed ID: 15339939
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Investigating the inhibitory effects of interferon-alpha on the replication of hepatitis C virus replicon].
    Jia YT; Wei L; Jiang D; Cong X; Fei R
    Zhonghua Yi Xue Za Zhi; 2005 Aug; 85(29):2065-9. PubMed ID: 16313804
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Interferon-resistant human melanoma cells are deficient in ISGF3 components, STAT1, STAT2, and p48-ISGF3gamma.
    Wong LH; Krauer KG; Hatzinisiriou I; Estcourt MJ; Hersey P; Tam ND; Edmondson S; Devenish RJ; Ralph SJ
    J Biol Chem; 1997 Nov; 272(45):28779-85. PubMed ID: 9353349
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Defective Jak-Stat activation in hepatoma cells is associated with hepatitis C viral IFN-alpha resistance.
    Zhu H; Nelson DR; Crawford JM; Liu C
    J Interferon Cytokine Res; 2005 Sep; 25(9):528-39. PubMed ID: 16181053
    [TBL] [Abstract][Full Text] [Related]  

  • 34. PCBP2 enhances the antiviral activity of IFN-α against HCV by stabilizing the mRNA of STAT1 and STAT2.
    Xin Z; Han W; Zhao Z; Xia Q; Yin B; Yuan J; Peng X
    PLoS One; 2011; 6(10):e25419. PubMed ID: 22022391
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of alpha interferon on the hepatitis C virus replicon.
    Guo JT; Bichko VV; Seeger C
    J Virol; 2001 Sep; 75(18):8516-23. PubMed ID: 11507197
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The human papilloma virus (HPV)-18 E6 oncoprotein physically associates with Tyk2 and impairs Jak-STAT activation by interferon-alpha.
    Li S; Labrecque S; Gauzzi MC; Cuddihy AR; Wong AH; Pellegrini S; Matlashewski GJ; Koromilas AE
    Oncogene; 1999 Oct; 18(42):5727-37. PubMed ID: 10523853
    [TBL] [Abstract][Full Text] [Related]  

  • 37. STAT1 is essential for the inhibition of hepatitis C virus replication by interferon-λ but not by interferon-α.
    Yamauchi S; Takeuchi K; Chihara K; Honjoh C; Kato Y; Yoshiki H; Hotta H; Sada K
    Sci Rep; 2016 Dec; 6():38336. PubMed ID: 27929099
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Blocking of the alpha interferon-induced Jak-Stat signaling pathway by Japanese encephalitis virus infection.
    Lin RJ; Liao CL; Lin E; Lin YL
    J Virol; 2004 Sep; 78(17):9285-94. PubMed ID: 15308723
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Interferon alpha decreases expression of human scavenger receptor class BI, a possible HCV receptor in hepatocytes.
    Murao K; Imachi H; Yu X; Cao WM; Nishiuchi T; Chen K; Li J; Ahmed RA; Wong NC; Ishida T
    Gut; 2008 May; 57(5):664-71. PubMed ID: 17998316
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Gene expression associated with interferon alfa antiviral activity in an HCV replicon cell line.
    Zhu H; Zhao H; Collins CD; Eckenrode SE; Run Q; McIndoe RA; Crawford JM; Nelson DR; She JX; Liu C
    Hepatology; 2003 May; 37(5):1180-8. PubMed ID: 12717400
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.